Home › Coronary Artery Disease › North Carolina › Raleigh
Coronary Artery Disease clinical trials in Raleigh, NC
6 studies for Coronary Artery Disease are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Duke Vascular Surgery and Vein Center at Brier Creek, Raleigh
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- NC Heart and Vascular Research, LLC, Raleigh
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- North Carolina Nephrology, PA, Raleigh
Product Surveillance Registry
RecruitingObservational study
- Raleigh, Raleigh
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Recruiting
- NC Heart and Vascular Research, LLC, Raleigh
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- NC Heart and Vascular Research, LLC, Raleigh
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY21 studies
- Boston, MA16 studies
- Dallas, TX15 studies
- Atlanta, GA15 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Cleveland, OH13 studies
- Nashville, TN11 studies
- Columbus, OH10 studies
- Durham, NC9 studies
- Los Angeles, CA8 studies
- Houston, TX8 studies
Other studies in Raleigh
- Heart Failure7 studies
- Obesity6 studies
- Type 2 Diabetes6 studies
- Macular Degeneration6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Endometrial Cancer5 studies
- Stroke5 studies
- Kidney Failure4 studies
- Diabetes4 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.